Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea

Multiple myeloma (MM) is the third most common hematologic malignancy in Korea. Historically, the incidence of MM in Korea has been lower than that in Western populations, although there is growing evidence that the incidence of MM in Asian populations, including Korea, is increasing rapidly. Despit...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Res
Päätekijät: Kim, Hyo Jung, Yoon, Sung-Soo, Eom, Hyeon Seok, Kim, Kihyun, Kim, Jin Seok, Lee, Je-Jung, Bang, Soo-Mee, Min, Chang-Ki, Park, Joon Seong, Lee, Jae-Hoon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Aiheet:
Review Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4377347/
https://ncbi.nlm.nih.gov/pubmed/25830125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.1.7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia